The DOI matches its Crossref record; 48 of the 49 references it cites were found in a registry or an index.
Privileged scaffolds for library design and drug discovery
Open accessAbstract
This review explores the concept of using privileged scaffolds to identify biologically active compounds through building chemical libraries. We hope to accomplish three main objectives: to provide one of the most comprehensive listings of privileged scaffolds; to reveal through four selected examples the present state of the art in privileged scaffold library synthesis (in hopes of inspiring new and even more creative approaches); and also to offer some thoughts on how new privileged scaffolds might be identified and exploited.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The fragment binding elements in our initial studies were selected based on their representation in drug-like molecules14 and were accordingly diverse in structure and physicochemical properties.”
From Expedited mapping of the ligandable proteome using fully functionalized enantiomeric probe pairs (2019) · cites this paper as [14]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The evolving role of natural products in drug discovery
Koehn, F. E., & Carter, G. T. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1657 · Cited by 2,579
Target-Oriented and Diversity-Oriented Organic Synthesis in Drug Discovery
Schreiber, S. L. (2000) · Science · doi:10.1126/science.287.5460.1964 · Cited by 2,571
Drugs for bad bugs: confronting the challenges of antibacterial discovery
Payne, D. J., Gwynn, M. N., Holmes, D. J., & Pompliano, D. L. (2007) · Nature Reviews Drug Discovery · doi:10.1038/nrd2201 · Cited by 2,512
A Planning Strategy for Diversity‐Oriented Synthesis
Burke, M. D., & Schreiber, S. L. (2003) · Angewandte Chemie International Edition · doi:10.1002/anie.200300626 · Cited by 1,493
Evans, B., Rittle, K. E., Bock, M. G., DiPardo, R. M., Freidinger, R. M., Whitter, W. L., Lundell, G. F., Veber, D. F., Anderson, P., Chang, R. S. L., et al. (1988) · Journal of Medicinal Chemistry · doi:10.1021/jm00120a002 · Cited by 1,460
Exploiting Chemical Libraries, Structure, and Genomics in the Search for Kinase Inhibitors
Gray, N. S., Wodicka, L. M., Thunnissen, A. M. W. H., Norman, T., Kwon, S., Espinoza, F. H., Morgan, D. O., Barnes, G., Leclerc, S., Meijer, L., et al. (1998) · Science · doi:10.1126/science.281.5376.533 · Cited by 808
From Nature to Drug Discovery: The Indole Scaffold as a ‘Privileged Structure’
Alves, F. R. S., Barreiro, E. J., & Fraga, C. A. M. (2009) · Mini-Reviews in Medicinal Chemistry · doi:10.2174/138955709788452649 · Cited by 606
Diversity-oriented synthesis: Exploring the intersections between chemistry and biology
Tan, D. S. (2005) · Nature Chemical Biology · doi:10.1038/nchembio0705-74 · Cited by 605
Privileged Structures: Applications in Drug Discovery
DeSimone, R., Currie, K., Mitchell, S. A., Darrow, J. W., & Pippin, D. A. (2004) · Combinatorial Chemistry & High Throughput Screening · doi:10.2174/1386207043328544 · Cited by 579
Towards the Optimal Screening Collection: A Synthesis Strategy
Nielsen, T. E., & Schreiber, S. L. (2007) · Angewandte Chemie International Edition · doi:10.1002/anie.200703073 · Cited by 553
Flagged first, then by citations
1 of the 49 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Items 201–300 of 1,000
Metal-Free Nitrogenation of 2-Acetylbiphenyls: Expeditious Synthesis of Phenanthridines
Tang, C., Yuan, Y., & Jiao, N. (2015) · Organic Letters · doi:10.1021/acs.orglett.5b00797 · Cited by 61
Gustafson, J. L., Lim, D., Barrett, K. T., & Miller, S. J. (2011) · Angewandte Chemie International Edition · doi:10.1002/anie.201101147 · Cited by 61
Multicomponent Assembly Strategies for the Synthesis of Diverse Tetrahydroisoquinoline Scaffolds
Granger, B. A., Kaneda, K., & Martin, S. F. (2011) · Organic Letters · doi:10.1021/ol201739u · Cited by 61
Visible‐Light‐Mediated 5‐exo‐dig Cyclizations of Amidyl Radicals
Reina, D. F., Dauncey, E. M., Morcillo, S. P., Svejstrup, T. D., Popescu, M. V., Douglas, J. J., Sheikh, N. S., & Leonori, D. (2017) · European Journal of Organic Chemistry · doi:10.1002/ejoc.201601607 · Cited by 61
Recent Trends and Observations in the Design of High-Quality Screening Collections
Renner, S., Popov, M., Schuffenhauer, A., ROTH, H. ‐., Breitenstein, W., Marzinzik, A. L., Lewis, I., Krastel, P., Nigsch, F., Jenkins, J. L., et al. (2011) · Future Medicinal Chemistry · doi:10.4155/fmc.11.15 · Cited by 61
Oh, S., Jang, H. J., Ko, S. K., Ko, Y., & Park, S. B. (2010) · Journal of Combinatorial Chemistry · doi:10.1021/cc100044w · Cited by 60
Kumar, R. R., Perumal, S., Menéndez, J. C., Yogeeswari, P., & Sriram, D. (2011) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2011.04.033 · Cited by 60
Data Sets Representative of the Structures and Experimental Properties of FDA-Approved Drugs
Douguet, D. (2018) · ACS Medicinal Chemistry Letters · doi:10.1021/acsmedchemlett.7b00462 · Cited by 59
Liu, L., Wang, D., Chen, F., Zhang, Z., Chen, Q., Xu, J., Wang, Z., & Zheng, G. (2020) · Catalysis Science & Technology · doi:10.1039/d0cy00071j · Cited by 60
Synthetic approaches to oligomeric natural products
Snyder, S. A., ElSohly, A. M., & Kontes, F. (2011) · Natural Product Reports · doi:10.1039/c1np00001b · Cited by 61
Self-citationOrganophotoredox‐Catalyzed Late‐Stage Functionalization of Heterocycles
Hota, S. K., Jinan, D., Panda, S. P., Pan, R., Sahoo, B., & Murarka, S. (2021) · Asian Journal of Organic Chemistry · doi:10.1002/ajoc.202100234 · Cited by 59
Active machine learning-driven experimentation to determine compound effects on protein patterns
Naik, A. W., Kangas, J. D., Sullivan, D. P., & Murphy, R. F. (2016) · eLife · doi:10.7554/elife.10047 · Cited by 62
Galdeano, C., & Ciulli, A. (2016) · Future Medicinal Chemistry · doi:10.4155/fmc-2016-0059 · Cited by 59
Svejstrup, T. D., Zawodny, W., Douglas, J. J., Bidgeli, D., Sheikh, N. S., & Leonori, D. (2016) · Chemical Communications · doi:10.1039/c6cc06029c · Cited by 59
Computer-Aided Drug Design: An Overview
Talevi, A. (2018) · Methods in molecular biology · doi:10.1007/978-1-4939-7756-7_1 · Cited by 59
Dong, J., Yue, F., Xu, W., Song, H., Liu, Y., & Wang, Q. (2020) · Green Chemistry · doi:10.1039/d0gc02111c · Cited by 59
Cu-Catalyzed Cross-Coupling of Nitroarenes with Aryl Boronic Acids to Construct Diarylamines
Guan, X., Zhu, H., & Driver, T. G. (2021) · ACS Catalysis · doi:10.1021/acscatal.1c03113 · Cited by 59
Qiu, Y., Yang, B., Zhu, C., & Bäckvall, J. (2016) · Journal of the American Chemical Society · doi:10.1021/jacs.6b09240 · Cited by 58
Nickel/NHC‐Catalyzed Enantioselective Cyclization of Pyridones and Pyrimidones with Tethered Alkenes
Shen, D., Zhang, W., Li, Z., Shi, S., & Xu, Y. (2020) · Advanced Synthesis & Catalysis · doi:10.1002/adsc.201901582 · Cited by 58
Biodiversity of small molecules – a new perspective in screening set selection
Petrone, P., Wassermann, A. M., Lounkine, E., Kutchukian, P. S., Simms, B., Jenkins, J. L., Selzer, P. M., & Glick, M. (2013) · Drug Discovery Today · doi:10.1016/j.drudis.2013.02.005 · Cited by 58
Schrӧder, F., Sharma, U. K., Mertens, M., Devred, F., Debecker, D. P., Luque, R., & der Eycken, E. V. V. (2016) · ACS Catalysis · doi:10.1021/acscatal.6b02443 · Cited by 58
Lead generation in crop protection research: a portfolio approach to agrochemical discovery
Loso, M. R., Garizi, N. V., Hegde, V. B., Hunter, J. E., & Sparks, T. C. (2016) · Pest Management Science · doi:10.1002/ps.4336 · Cited by 57
Tian, H., Xue, W., Wu, J., Yang, Z., Lu, H., & Tang, C. (2022) · Organic Chemistry Frontiers · doi:10.1039/d2qo00683a · Cited by 57
Catalytic remodeling of complex alkenes to oxonitriles through C=C double bond deconstruction
Cheng, Z., Huang, K., Wang, C., Chen, L., Li, X., Hu, Z., Shan, X., Cao, P., Sun, H., Chen, W., et al. (2025) · Science · doi:10.1126/science.adq8918 · Cited by 57
Privileged Structures - Dream or Reality: Preferential Organization of Azanaphthalene Scaffold
Polański, J., Kurczyk, A., Bąk, A., & Musioł, R. (2012) · Current Medicinal Chemistry · doi:10.2174/092986712800167356 · Cited by 59
Palladium‐Catalyzed Cascade Cyclization of Ynamides to Azabicycles
Greenaway, R. L., Campbell, C. D., Holton, O. T., Russell, C. A., & Anderson, E. A. (2011) · Chemistry - A European Journal · doi:10.1002/chem.201102880 · Cited by 57
Echemendía, R., de la Torre, A. F., Monteiro, J. L., Pila, M., Corrêa, A. G., Westermann, B., Rivera, D. G., & Paixão, M. W. (2015) · Angewandte Chemie International Edition · doi:10.1002/anie.201412074 · Cited by 57
Shi, Z., Grohmann, C., & Glorius, F. (2013) · Angewandte Chemie · doi:10.1002/ange.201301426 · Cited by 57
Computer-Aided Drug Discovery and Design: Recent Advances and Future Prospects
Talevi, A. (2023) · Methods in molecular biology · doi:10.1007/978-1-0716-3441-7_1 · Cited by 58
He, X., Zou, P., Qiu, J., Hou, L., Jiang, S., Liu, S., & Xie, L. (2011) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2011.09.047 · Cited by 56
Rajule, R. N., Bryant, V. C., López-Bertoni, H., Luo, X., & Natarajan, A. (2012) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2012.02.022 · Cited by 56
Antifibrotic and anticancer action of 5-ene amino/iminothiazolidinones
Kaminskyy, D. V., den Hartog, G. J. M., Wojtyra, M., Lelyukh, M. I., Gzella, A. K., Bast, A., & Lesyk, R. (2016) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2016.02.011 · Cited by 56
Quinoline-based HIV Integrase Inhibitors
Musioł, R. (2013) · Current Pharmaceutical Design · doi:10.2174/1381612811319100008 · Cited by 57
A Short Review on Synthetic Advances toward the Synthesis of Rufinamide, an Antiepileptic Drug
Padmaja, R. D., & Chanda, K. (2018) · Organic Process Research & Development · doi:10.1021/acs.oprd.7b00373 · Cited by 55
Cycloisomerization of Olefins in Water
Matos, J. L. M., Green, S. A., Chun, Y., Dang, V. Q., Dushin, R. G., Richardson, P., Chen, J. S., Piotrowski, D. W., Paegel, B. M., & Shenvi, R. A. (2020) · Angewandte Chemie International Edition · doi:10.1002/anie.202003948 · Cited by 56
Deep Lead Optimization: Leveraging Generative AI for Structural Modification
Zhang, O., Lin, H., Zhang, H., Zhao, H., Huang, Y., Hsieh, C., Pan, P., & Hou, T. (2024) · Journal of the American Chemical Society · doi:10.1021/jacs.4c11686 · Cited by 64
Jacobsen, C. B., Meldal, M., & Diness, F. (2016) · Chemistry - A European Journal · doi:10.1002/chem.201604098 · Cited by 55
El-Agrody, A. M., Fouda, A. M., Assiri, M. A., Mora, A., Tarik El-Sayed, A. L. I., Alam, M. M., & Alfaifi, M. Y. (2020) · Medicinal Chemistry Research · doi:10.1007/s00044-019-02494-3 · Cited by 55
Wang, Z., Zheng, S., Matsui, J. K., Lu, Z., & Molander, G. A. (2019) · Chemical Science · doi:10.1039/c9sc00776h · Cited by 54
Linguistic measures of chemical diversity and the “keywords” of molecular collections
Woźniak, M., Wołos, A., Modrzyk, U., Górski, R. L., Winkowski, J., Bajczyk, M. D., Szymkuć, S., Grzybowski, B. A., & Eder, M. (2018) · Scientific Reports · doi:10.1038/s41598-018-25440-6 · Cited by 54
The piperazine scaffold for novel drug discovery efforts: the evidence to date
Romanelli, M. N., Manetti, D., Braconi, L., Dei, S., Gabellini, A., & Teodori, E. (2022) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2022.2103535 · Cited by 53
Vu, B. T., Dominique, R., Fahr, B. J., Li, H. H., Fry, D. C., Xu, L., Yang, H. Y., Puzio‐Kuter, A. M., Good, A. C., Liu, B., et al. (2024) · ACS Medicinal Chemistry Letters · doi:10.1021/acsmedchemlett.4c00379 · Cited by 57
Asati, V., & Bharti, S. K. (2017) · Journal of Molecular Structure · doi:10.1016/j.molstruc.2017.10.077 · Cited by 53
Catalytic Asymmetric Synthesis of α‐Arylpyrrolidines and Benzo‐fused Nitrogen Heterocycles
Dai, X., Engl, O. D., León, T., & Buchwald, S. L. (2019) · Angewandte Chemie International Edition · doi:10.1002/anie.201814331 · Cited by 53
Jagannathan, R. (2019) · ACS Omega · doi:10.1021/acsomega.8b01764 · Cited by 53
Fan, Z., Bay, K. L., Chen, X., Zhuang, Z., Park, H. S., Yeung, K., Houk, K. N., & Yu, J. (2020) · Angewandte Chemie International Edition · doi:10.1002/anie.201915624 · Cited by 53
Carboxyboronate: A Versatile C1 Building Block
Holownia, A., Tien, C., Diaz, D. B., Larson, R. T., & Yudin, A. K. (2019) · Angewandte Chemie International Edition · doi:10.1002/anie.201907486 · Cited by 52
Domino transformation of isoxazoles to 2,4-dicarbonylpyrroles under Fe/Ni relay catalysis
Galenko, E. E., Galenko, A. V., Khlebnikov, A. F., & Novikov, M. S. (2015) · RSC Advances · doi:10.1039/c5ra01889g · Cited by 52
Chua, Y., & Duong, H. A. (2014) · Chemical Communications · doi:10.1039/c4cc02930e · Cited by 52
Pyridine Based Antitumour Compounds Acting at the Colchicine Site
Álvarez, R., Aramburu, L., Puebla, P., Caballero, E., González, M., Vicente, A. A., Medarde, M., & Peláez, R. (2016) · Current Medicinal Chemistry · doi:10.2174/092986732311160420104823 · Cited by 52
Adams, K., Ball, A. K., Birkett, J., Brown, L., Chappell, B. G. N., Gill, D. M., Lo, P. K. T., Patmore, N. J., Rice, C. R., Ryan, J., et al. (2016) · Nature Chemistry · doi:10.1038/nchem.2670 · Cited by 52
Lewis Base–Boryl Radicals Enabled the Desulfurizative Reduction and Annulation of Thioamides
Yu, Y., Zhang, F., Cheng, J. L., Hei, J., Deng, W., & Wang, Y. (2017) · Organic Letters · doi:10.1021/acs.orglett.7b03201 · Cited by 52
Marcote, D. C., Varela-Aneiros, I., Fernández-Casado, J., Mascarenas, J. L., & López, F. (2018) · Journal of the American Chemical Society · doi:10.1021/jacs.8b10388 · Cited by 52
Karmel, C., Rubel, C., Kharitonova, E. V., & Hartwig, J. F. (2020) · Angewandte Chemie International Edition · doi:10.1002/anie.201916015 · Cited by 52
Gunasekaran, P., Balamurugan, K., Sivakumar, S., Perumal, S., Menéndez, J. C., & Almansour, A. I. (2012) · Green Chemistry · doi:10.1039/c2gc16517a · Cited by 51
Recent Advances on the C2-Functionalization of Indole via Umpolung
Deka, B., Deb, M. L., & Baruah, P. K. (2020) · Topics in Current Chemistry · doi:10.1007/s41061-020-0287-7 · Cited by 51
Exploring and mapping chemical space with molecular assembly trees
Liu, Y., Mathis, C., Bajczyk, M. D., Marshall, S. M., Wilbraham, L., & Cronin, L. (2021) · Science Advances · doi:10.1126/sciadv.abj2465 · Cited by 49
Hezarcheshmeh, N. K., & Azizian, J. (2022) · Molecular Diversity · doi:10.1007/s11030-021-10311-6 · Cited by 51
Huang, W., Keeß, S., & Molander, G. A. (2023) · Angewandte Chemie International Edition · doi:10.1002/anie.202302223 · Cited by 51
Micco, S. D., Spatafora, C., Cardullo, N., Riccio, R., Fischer, K., Pergola, C., Koeberle, A., Werz, O., Chalal, M., Fasseur, D., et al. (2016) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2016.01.002 · Cited by 50
Wang, Y., Tian, J., Tan, P., Cao, Q., Zhang, X., Cao, Z., Zhou, F., Wang, X., & Zhou, J. E. (2019) · Angewandte Chemie International Edition · doi:10.1002/anie.201910864 · Cited by 51
Al‐Raqa, S. Y., Alharbi, K., Aljuhani, A., Rezki, N., Aouad, M. R., & Ali, I. (2020) · Journal of Molecular Structure · doi:10.1016/j.molstruc.2020.129192 · Cited by 51
Zhang, Y., Wang, S., Wu, S., Zhu, S., Dong, G., Miao, Z., Yao, J., Zhang, W., Sheng, C., & Wang, W. (2013) · ACS Combinatorial Science · doi:10.1021/co400022r · Cited by 51
1,2,3,4-Tetrahydroisoquinoline (THIQ) as privileged scaffold for anticancer de novo drug design
Faheem, F., Kumar, B. K., Sekhar, K. V. G. C., Chander, S., Kunjiappan, S., & Murugesan, S. (2021) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2021.1916464 · Cited by 52
Medium‐Ring Nitrogen Heterocycles through Migratory Ring Expansion of Metalated Ureas
Hall, J. E., Matlock, J. V., Ward, J. W., Gray, K. V., & Clayden, J. (2016) · Angewandte Chemie · doi:10.1002/ange.201605714 · Cited by 50
Mei, L., Chen, H., Dong, A.-Y., Huang, G.-Y., Liu, Y.-W., Zhang, X., Wang, W., Hao, G., & Yang, G. (2022) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.2c02141 · Cited by 50
Scaffold Flatness: Reversing the Trend
Tajabadi, F. M., Campitelli, M. R., & Quinn, R. J. (2013) · Springer Science Reviews · doi:10.1007/s40362-013-0014-7 · Cited by 51
Zhang, A., Fang, H., Wang, Y., Yan, G., Sun, H. J., Zhou, X., Wang, Y., Liu, L., & Wang, X. (2017) · RSC Advances · doi:10.1039/c7ra09522h · Cited by 49
Oxidative Condensations To Form Benzimidazole-Substituted Potassium Organotrifluoroborates
Molander, G. A., & Ajayi, K. (2012) · Organic Letters · doi:10.1021/ol301956p · Cited by 49
Ligand specificity, privileged substructures and protein druggability from fragment-based screening
Barelier, S., & Krimm, I. (2011) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2011.02.020 · Cited by 49
Strategies of multi-objective optimization in drug discovery and development
Nicolotti, O., Giangreco, I., Introcaso, A., Leonetti, F., Stefanachi, A., & Carotti, A. (2011) · Expert Opinion on Drug Discovery · doi:10.1517/17460441.2011.588696 · Cited by 48
Patil, N. T., Lakshmi, P. G. V. V., Sridhar, B., Patra, S., Bhadra, M. P., & Patra, C. R. (2012) · European Journal of Organic Chemistry · doi:10.1002/ejoc.201101822 · Cited by 49
Tryba, M., Linde, I., Voshage, G., & Zenz, M. (1991) · PubMed · Cited by 49
Behera, D., Thiyagarajan, S., Anjalikrishna, P. K., Suresh, C. H., & Gunanathan, C. (2021) · ACS Catalysis · doi:10.1021/acscatal.1c01148 · Cited by 48
The Rhodadyns, a New Class of Small Molecule Inhibitors of Dynamin GTPase Activity
Robertson, M. J., Hadzic, G., Ambrus, J. I., Pomè, D. Y., Hyde, E. D. E. R., Whiting, A., Mariana, A., von Kleist, L., Chau, N., Haucke, V., et al. (2012) · ACS Medicinal Chemistry Letters · doi:10.1021/ml200284s · Cited by 48
Parra, A., Martin-Fonseca, S., Rivas, F., Reyes‐Zurita, F. J., Medina‐O’Donnell, M., Martı́nez, A., García‐Granados, A., Lupiáñez, J. A., & Alberício, F. (2014) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2013.12.049 · Cited by 48
Li, X., Herrmann, J. E., Zang, Y., Grellier, P., Prado, S., Müller, R., & Nay, B. (2013) · Beilstein Journal of Organic Chemistry · doi:10.3762/bjoc.9.176 · Cited by 48
Indanes—Properties, Preparation, and Presence in Ligands for G Protein Coupled Receptors
Vilums, M., Heuberger, J. A. A. C., Heitman, L. H., & IJzerman, A. P. (2015) · Medicinal Research Reviews · doi:10.1002/med.21352 · Cited by 49
Thikekar, T. U., & Sun, C. (2017) · Advanced Synthesis & Catalysis · doi:10.1002/adsc.201700741 · Cited by 48
Late‐Stage Alkylation of Heterocycles Using N‐(Acyloxy)phthalimides
Parida, S. K., Hota, S. K., Kumar, R., & Murarka, S. (2021) · Chemistry - An Asian Journal · doi:10.1002/asia.202100151 · Cited by 48
Mo, K., Zhou, X., Wu, J., & Zhao, Y. (2022) · Organic Letters · doi:10.1021/acs.orglett.2c00530 · Cited by 47
Catalyst-free visible-light-induced decarbonylative C–H alkylation of quinoxalin-2(1 H )-ones
Shi, X., Cao, Y., Liu, Y., Niu, K., Song, H., Zhang, J., & Wang, Q. (2023) · Organic Chemistry Frontiers · doi:10.1039/d2qo02019j · Cited by 47
Design and synthesis of 2-aminothiazole based antimicrobials targeting MRSA
Annadurai, S., Martinez, R. L., Canney, D. J., Eidem, T. M., Dunman, P. M., & Abou-Gharbia, M. A. (2012) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2012.09.095 · Cited by 47
Identification of a novel class of quinoline–oxadiazole hybrids as anti-tuberculosis agents
Jain, P. P., Degani, M. S., Raju, A., Anantram, A., Seervi, M., Sathaye, S. S., Ray, M., & Rajan, M. G. R. (2015) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2015.11.057 · Cited by 47
Rogers, D. A., Bensalah, A. T., Espinosa, A. T., Hoerr, J. L., Refai, F. H., Pitzel, A. K., Alvarado, J. J., & Lamar, A. A. (2019) · Organic Letters · doi:10.1021/acs.orglett.9b01414 · Cited by 47
Pitchai, A., Rajaretinam, R. K., & Freeman, J. L. (2019) · Medicines · doi:10.3390/medicines6020061 · Cited by 49
Selectivity in the Elaboration of Bicyclic Borazarenes
Bhattacharjee, A., Davies, G. H. M., Saeednia, B., Wisniewski, S. R., & Molander, G. A. (2020) · Advanced Synthesis & Catalysis · doi:10.1002/adsc.202001384 · Cited by 46
Bartoloni, M., Jin, X., Marcaida, M. J., Banha, J., Bonaventura, I. D., Bongoni, S., Bartho, K., Gräbner, O., Sefkow, M., Darbre, T., et al. (2015) · Chemical Science · doi:10.1039/c5sc01699a · Cited by 46
Nguyen, K., Clement, H. A., Bernier, L., Coe, J. W., Farrell, W. P., Helal, C. J., Reese, M. R., Sach, N. W., Lee, J. C., & Hall, D. G. (2020) · ACS Catalysis · doi:10.1021/acscatal.0c04520 · Cited by 46
Havasi, F., Ghorbani‐Choghamarani, A., & Nikpour, F. (2015) · Microporous and Mesoporous Materials · doi:10.1016/j.micromeso.2015.10.036 · Cited by 45
The Purchasable Chemical Space: A Detailed Picture
Lucas, X., Grüning, B. A., Bleher, S., & Günther, S. (2015) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.5b00116 · Cited by 46
Mild Cobalt‐Catalyzed Negishi Cross‐Couplings of (Hetero)arylzinc Reagents with (Hetero)aryl Halides
Haas, D., Hammann, J. M., Lutter, F. H., & Knochel, P. (2016) · Angewandte Chemie International Edition · doi:10.1002/anie.201510665 · Cited by 45
Alamillo‐Ferrer, C., Karabourniotis‐Sotti, M., Kennedy, A. R., Campbell, M. J., & Tomkinson, N. C. O. (2016) · Organic Letters · doi:10.1021/acs.orglett.6b01253 · Cited by 45
Design, synthesis and DNA-binding study of some novel morpholine linked thiazolidinone derivatives
War, J. A., Srivastava, S. K., & Srivastava, S. K. (2016) · Spectrochimica Acta Part A Molecular and Biomolecular Spectroscopy · doi:10.1016/j.saa.2016.07.054 · Cited by 45
Hazra, G., Maity, S., Bhowmick, S., & Ghorai, P. (2017) · Chemical Science · doi:10.1039/c6sc04522g · Cited by 45
Dong, Z., Zhang, X., Li, W., Li, Z., Wang, W., Zhang, Y., Liu, W., & Liu, W.-B. (2019) · Organic Letters · doi:10.1021/acs.orglett.8b04128 · Cited by 45
Potowski, M., Kunig, V. B. K., Losch, F., & Brunschweiger, A. (2019) · MedChemComm · doi:10.1039/c9md00042a · Cited by 45
Zhang, S., Chen, F., He, Y., & Fan, Q. (2019) · Organic Letters · doi:10.1021/acs.orglett.9b01859 · Cited by 45
The 2,11-Cyclized Cembranoids: Cladiellins, Asbestinins, and Briarellins (Period 1998–2010)
Welford, A. J., & Collins, I. (2011) · Journal of Natural Products · doi:10.1021/np200125v · Cited by 45
Synthesis of Alkyl Aryl(heteroaryl)acetates from N-Oxides, 1,1-Difluorostyrenes, and Alcohols
Loska, R., Szachowicz, K., & Szydlik, D. (2013) · Organic Letters · doi:10.1021/ol402735m · Cited by 45
Metadata
- Authors
- Welsch, M. E., Snyder, S. A., & Stockwell, B. R.
- Affiliations
- Columbia University (US)
- Howard Hughes Medical Institute (US)
- Corresponding author
- Snyder, Scott A
- Stockwell, Brent R
- Venue
- Current Opinion in Chemical Biology
- Publisher
- Elsevier BV
- Published
- 2010-06
- Volume
- 14
- Issue
- 3
- Pages
- 347-361
- ISSN
- 1367-5931 (ISSN-L)
- PMC
- PMC2908274
- OpenAlex
- W2162106505
- Cited by
- 1,509
- References
- 49
- Citations by year
- 2026: 83 · 2025: 84 · 2024: 97 · 2023: 101 · 2022: 111 · 2021: 102 · 2020: 109 · 2019: 119 · 2018: 108 · 2017: 114 · 2016: 104 · 2015: 96 · 2014: 91 · 2013: 69 · 2012: 53
- FWCI
- 5.29
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- Locations
- Current Opinion in Chemical Biology (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- Howard Hughes Medical Institute
- Arnold and Mabel Beckman Foundation
- Research Corporation for Science Advancement
- Eli Lilly and Company
- National Cancer Institute (RC2CA148308, R01CA097061)
- National Institute of General Medical Sciences (R01GM084994, R01GM085081, R01-GM84994)
- Topics
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Drug Discovery › Computational Drug Discovery Methods
- Physical Sciences › Chemistry › Organic Chemistry › Chemical Synthesis and Analysis
- Physical Sciences › Chemistry › Organic Chemistry › Heterocyclic Compound Synthesis and Bioactivity
- Keywords
- privileged scaffolds, chemical libraries, library design, drug discovery, scaffold-based drug design, chemical library synthesis, bioactive compounds
- MeSH terms
- Pharmaceutical Preparations, Humans, Models, Chemical, Protein Binding, Drug Delivery Systems, Receptors, Cytoplasmic and Nuclear, Small Molecule Libraries, Drug Discovery
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review